HB1754 - 104th General Assembly
| |||||||
| |||||||
| 1 | AMENDMENT TO HOUSE BILL 1754 | ||||||
| 2 | AMENDMENT NO. ______. Amend House Bill 1754 by replacing | ||||||
| 3 | everything after the enacting clause with the following: | ||||||
| 4 | "Section 1. Short title; references to Act. | ||||||
| 5 | (a) This Act may be cited as the Tracking Infectious Cases | ||||||
| 6 | Knowledgeably Act. | ||||||
| 7 | (b) This Act may be referred to as the TICK Act. | ||||||
| 8 | Section 5. Findings. The General Assembly finds that | ||||||
| 9 | alpha-gal syndrome (AGS) is a serious and potentially | ||||||
| 10 | life-threatening allergic condition that can occur after a | ||||||
| 11 | tick bite. AGS is named for a molecule, known as alpha-gal or | ||||||
| 12 | the Galili antigen, that is found in most mammals. Symptoms of | ||||||
| 13 | AGS occur after people eat red meat or are exposed to other | ||||||
| 14 | products made from mammals. Because of this, AGS is also known | ||||||
| 15 | as the red meat allergy or tick bite meat allergy. The Centers | ||||||
| 16 | for Disease Control and Prevention (CDC) has identified AGS as | ||||||
| |||||||
| |||||||
| 1 | a growing threat to clinical and public health and has | ||||||
| 2 | identified state-level surveillance of AGS as a critical need. | ||||||
| 3 | The CDC has identified Illinois as a state with one of the | ||||||
| 4 | highest AGS prevalence rates in the nation. | ||||||
| 5 | Section 10. Definitions. In this Act: | ||||||
| 6 | "Alpha-gal syndrome" or "AGS" means an acquired | ||||||
| 7 | delayed-type allergic reaction to a sugar molecule called | ||||||
| 8 | alpha-galactose (alpha-gal), which is typically caused by the | ||||||
| 9 | bite of an infected lone star tick and can cause serious, | ||||||
| 10 | potentially life-threatening allergic reactions to consuming | ||||||
| 11 | meat or other products containing alpha-gal. | ||||||
| 12 | "Diagnosis" means identification as having Lyme disease or | ||||||
| 13 | alpha-gal syndrome, either clinically or with laboratory | ||||||
| 14 | testing confirmation, by (1) a physician licensed to practice | ||||||
| 15 | medicine in all its branches, (2) a person otherwise permitted | ||||||
| 16 | to diagnose Lyme disease or alpha-gal syndrome by applicable | ||||||
| 17 | laws, or (3) another appropriately licensed person under the | ||||||
| 18 | supervision of or in collaboration with a physician licensed | ||||||
| 19 | to practice medicine in all its branches. | ||||||
| 20 | Section 15. Alpha-gal syndrome education. The Department | ||||||
| 21 | of Public Health shall provide educational materials regarding | ||||||
| 22 | alpha-gal syndrome data on its website where applicable. The | ||||||
| 23 | Department of Public Health shall undertake an awareness and | ||||||
| 24 | education campaign for community members, local health | ||||||
| |||||||
| |||||||
| 1 | departments, and medical providers on the signs and symptoms | ||||||
| 2 | of alpha-gal syndrome, including education on proper | ||||||
| 3 | procedures by which to order a test for diagnosis of alpha-gal | ||||||
| 4 | syndrome. | ||||||
| 5 | Section 99. Effective date. This Act takes effect upon | ||||||
| 6 | becoming law.". | ||||||
